Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HIV
Pharma
GSK bolsters case for long-acting HIV PrEP drug Apretude
With GSK girding for competition from Gilead, the company has presented strong results from three real-world studies of HIV prevention drug Apretude.
Kevin Dunleavy
Oct 16, 2024 1:26pm
Theratechnologies' HIV med may run short due to contractor issue
Sep 18, 2024 12:11pm
Gilead aims to shake up HIV PrEP market with long-acting launch
Aug 9, 2024 11:42am
What 'The Next Berlin Patient' means for HIV drug development
Aug 2, 2024 9:43am
GSK's Dovato matches Gilead's Biktarvy with less weight gain
Jul 23, 2024 4:00am
US appeals Gilead's trial win in Truvada, Descovy patent fight
Jul 9, 2024 11:00am
